SCHEMBL3385362

SCHEMBL3385362

[CH2]CCCC(CC)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
CCR5 P51681 1/20 0.40
NR1I2 O75469 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
HRH1 P35367 6/20 0.37
HTR2A P28223 5/20 0.37
TAAR1 Q96RJ0 2/20 0.36
CYP2D6 P10635 1/20 0.36
MIF P14174 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HKDC1 Q2TB90 1/20 0.34
TRPA1 O75762 1/20 0.34
AOC3 Q16853 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9869713 0.94 SIGMAR1 (0.42) LMNACCR5NR1I2SIGMAR1HRH1
SCHEMBL3390551 0.92 NR1I2 (0.44) LMNACCR5NR1I2SIGMAR1HRH1
SCHEMBL17183686 0.92 NR1I2 (0.44) LMNACCR5NR1I2SIGMAR1HRH1
SCHEMBL27567790 0.92 NR1I2 (0.44) LMNACCR5NR1I2SIGMAR1HRH1
SCHEMBL17183751 0.92 NR1I2 (0.44) LMNACCR5NR1I2SIGMAR1HRH1
SCHEMBL11099949 0.92 NR1I2 (0.44) LMNACCR5NR1I2SIGMAR1HRH1
SCHEMBL15061554 0.88 LMNA (0.45) LMNACCR5SIGMAR1HRH1HTR2A
SCHEMBL536830 0.88 LMNA (0.45) LMNACCR5SIGMAR1HRH1HTR2A
SCHEMBL3316490 0.86 AOC3 (0.40) LMNASIGMAR1HRH1HTR2AKDM4E
SCHEMBL15563156 0.86 POLB (0.41) LMNASIGMAR1HRH1HTR2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205199-A1 Dermatological Cosmetic Composition Comprising an SDKP Peptide or an Analog Thereof RPM DERMATOLOGIE (FR) 2021-07-08 US disclosed
EP-3416730-B1 DERMATOLOGICAL COSMETIC COMPOSITION COMPRISING AN SDKP PEPTIDE OR AN ANALOG THEREOF RPM DERMATOLOGIE (FR) 2021-07-07 EP disclosed
WO-2021107870-A1 ANTIMICROBIAL AGENT, COATING FORMULATION, COMPOSITE SURFACE COATING AND METHODS OF PREPARING THE SAME AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2021-06-03 WO disclosed
EP-3239111-B1 CURABLE COMPOSITION, TRANSFER FILM, FRONT PLATE OF IMAGE DISPLAY DEVICE, FRONT PLATE-INTEGRATED SENSOR, IMAGE DISPLAY DEVICE, AND MANUFACTURING METHOD FOR FRONT PLATE OF IMAGE DISPLAY DEVICE FUJIFILM CORP (JP) 2021-02-17 EP disclosed
EP-3416730-A1 DERMATOLOGICAL COSMETIC COMPOSITION COMPRISING AN SDKP PEPTIDE OR AN ANALOG THEREOF RPM Dermatologie (FR) 2018-12-26 EP disclosed
US-10035927-B2 Coloring composition for decoration, decorative material, base material having decorative material, transfer material, touch panel, and information display device FUJIFILM CORPORATION (JP) 2018-07-31 US disclosed
EP-3239111-A1 CURABLE COMPOSITION, TRANSFER FILM, FRONT PLATE OF IMAGE DISPLAY DEVICE, FRONT PLATE-INTEGRATED SENSOR, IMAGE DISPLAY DEVICE, AND MANUFACTURING METHOD FOR FRONT PLATE OF IMAGE DISPLAY DEVICE FUJIFILM Corporation (JP) 2017-11-01 EP disclosed
US-9802902-B2 Antifungal compound AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-10-31 US disclosed
WO-2017140997-A1 DERMATOLOGICAL COSMETIC COMPOSITION COMPRISING AN SDKP PEPTIDE OR AN ANALOG THEREOF RPM DERMATOLOGIE (FR) 2017-08-24 WO disclosed
CN-104903409-B Heat resistance decoration coloured composition, the manufacture method of capacitive input device and capacitive input device and possesses this image display device 富士胶片株式会社 2017-08-11 CN disclosed
US-9493424-B2 Antifungal compound AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-11-15 US disclosed
US-9268451-B2 Transfer film, manufacturing method of capacitive input device, capacitive input device, and image display device including the same FUJIFILM CORPORATION (JP) 2016-02-23 US disclosed
CN-104903409-A Heat-resistant decorating coloring composition, method for producing electrostatic capacitance type input device, and electrostatic capacitance type input device, as well as image display device provided with same FUJIFILM CORP 2015-09-09 CN disclosed
US-20150203454-A1 ANTIFUNGAL COMPOUND AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-07-23 US disclosed
US-20150092123-A1 TRANSFER FILM, MANUFACTURING METHOD OF CAPACITIVE INPUT DEVICE, CAPACITIVE INPUT DEVICE, AND IMAGE DISPLAY DEVICE INCLUDING THE SAME FUJIFILM CORPORATION (JP) 2015-04-02 US disclosed
CN-104321195-A Transfer film, method for producing capacitive input device, capacitive input device, and image display device provided with same FUJIFILM CORP 2015-01-28 CN disclosed
WO-2014025314-A1 An Antifungal Compound AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-02-13 WO disclosed
WO-2010094721-A1 PIPERIDIN-PYRIMIDINE DERIVATIVES AS ANTAGONISTS OF HISTAMINE H4 RECEPTOR PALAU PHARMA, S. A. (ES) 2010-08-26 WO disclosed
WO-2010043633-A1 2H-PYRAZOLO [4,3-D]PYRIMIDIN-5-AMINE DERIVATIVES AS H4 HISTAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ALLERGIC, IMMUNOLOGICAL AND INFLAMMATORY DISEASES PALAU PHARMA, S. A. (ES) 2010-04-22 WO disclosed
CN-1179773-A Cyclohexylamino and cyclohexylalkoxy nitrogen heterocycles, methods of preparing them and their use as pest-control agents and fungicides HOECHST SCHERING AGREVO GMBH (DE) 1998-04-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203454-A1 ANTIFUNGAL COMPOUND ERG28, DPM1, BAK1 LMNA 2940/4885CCR5 3090/4885NR1I2 2814/4885
US-20210205199-A1 Dermatological Cosmetic Composition Comprising an SDKP Peptide or an Analog Thereof CUTA, SDAD1, SDCBP LMNA 1012/4885CCR5 3958/4885NR1I2 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.